Brief: OrganiGram Makes Additional $2.5 Mln Investment In Hyasynth Biologicals
22/12/2021 13:19
Dec 22 (Reuters) - OrganiGram Holdings Inc OGI.TO :
* ORGANIGRAM MAKES ADDITIONAL $2.5 MILLION INVESTMENT IN
HYASYNTH
BIOLOGICALS, A LEADING CANNABINOID BIOSYNTHESIS COMPANY
Source text for Eikon: ID:nBwbnzNjka
Further company coverage: OGI.TO
Recent news on Organigram Global
See all newsBrief: Organigram Global Expects Annualized Run-Rate Cost Savings Of $8 Million-$10 Million In Fiscal 2027
Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit
Brief: Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million
Brief: Organigram Provides Business Update Highlighting Initial Sanity Performance And Canadian Market Share
Canada cannabis producer Organigram's Q2 net revenue falls more than expected